F2RL3 and ovarian carcinoma: Since thrombosis is a complex process that involves multiple agonists in vivo, we next asked if ovarian cancer cells modulated agonist [TRAP, PAR 4 agonist, Arachidonic Acid, ADP, epinephrine, and Collagen] induced platelet activation.